4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-24-022037
CEO, CFO, Director gave up 2,033 shares (to pay taxes)
- CEO, CFO, Director acquired 7,068 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2024-05-28 | Option exercise | +1,622 | 10,059 | D: show line 1 in the form | ||
| Finley John David CEO, CFO, Director | 2024-05-28 | Shares withheld for taxes | −467 | $4.76 | $2,223 | 9,592 | D: show line 2 in the form |
| Finley John David CEO, CFO, Director | 2024-05-28 | Option exercise | +3,335 | 12,927 | D: show line 3 in the form | ||
| Finley John David CEO, CFO, Director | 2024-05-28 | Shares withheld for taxes | −959 | $4.76 | $4,565 | 11,968 | D: show line 4 in the form |
| Finley John David CEO, CFO, Director | 2024-05-28 | Option exercise | +2,111 | 14,079 | D: show line 5 in the form | ||
| Finley John David CEO, CFO, Director | 2024-05-28 | Shares withheld for taxes | −607 | $4.76 | $2,889 | 13,472 | D: show line 6 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2024-05-28 | Option exercise · Restricted Stock Units | −1,622 | 0 | D: show line 7 in the form | |||||
| Finley John David CEO, CFO, Director | 2024-05-28 | Option exercise · Restricted Stock Units | −3,335 | 0 | D: show line 8 in the form | |||||
| Finley John David CEO, CFO, Director | 2024-05-28 | Option exercise · Restricted Stock Units | −2,111 | 0 | D: show line 9 in the form |
Loading xslF345X05/ownership.xml…